A Bold Step Reflecting Customer Obsession, Strategic Growth, and a New Era for Instem
Instem, a global leader in SaaS solutions for life sciences R&D, today announced the official opening of its new global headquarters in Boston, Massachusetts, strategically located in one of the world’s foremost biotech innovation hubs.
This significant milestone marks more than just a change in location, it reflects the emergence of a new Instem, with an unwavering focus on customer-obsession, operational excellence, and delivering on a bold strategic vision. The new headquarters signals Instem’s commitment to being closer to its clients, partners, and talent in the heart of the global life sciences ecosystem.
“The launch of our Boston headquarters represents a turning point in Instem’s transformation,” said Vik Krishnan, CEO of Instem. “It’s not just about geography, it’s about focus. We are aligning our organization around what matters most: delivering value to our customers faster, with deeper insight and stronger support. This new home is a symbol of how we’re scaling smartly and growing with purpose.”
The new office, located within the iconic Prudential Center in Boston’s historic Back Bay, offers world-class facilities and connectivity for Instem staff, clients, and stakeholders. The move supports the company’s accelerated growth strategy, which includes the recent strategic acquisitions of RockStep Solutions, Xybion, and Autoscribe Informatics, each expanding Instem’s footprint and solution set in core R&D domains.
The inauguration event, attended by senior leadership, local team members, and board members, highlighted Instem’s ongoing investment in its people, culture, and customer experience. The new headquarters will serve as a central hub for collaboration, innovation, and integration across business units and regions.
Instem’s Boston presence underscores its commitment to building stronger, more responsive partnerships with clients across North America and beyond. It brings the organization even closer to decision makers in the pharmaceutical, biotech, and CRO sectors and enables faster, more tailored support across the entire product portfolio.
“This move is a tangible representation of our strategy in action,” said Krishnan. “We are investing in the right places, hiring the right talent, and empowering teams to execute with clarity. As we continue to evolve, this headquarters will be a cornerstone of how we deliver meaningful outcomes for our customers and partners worldwide.”
About Instem
Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Founded in the United Kingdom in 1969, Instem has deep roots internationally across North America, EMEA and APAC. Instem maintains a commercial and technical presence throughout these regions and prides itself on localized support for its diverse client base. Instem has been an ARCHIMED company since 2023.
Learn more about Instem here: www.instem.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20251202879549/en/
Contacts
Press: Mike Thurogood, VP Global Marketing: mike.thurogood@instem.com